Paper22010102
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.
Jagasia M and 21 others. Blood, 2012. Cited by 573 papers, by iCite.
Cite this record
ConductScience Library. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Papers, record 22010102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22010102
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| Hematologic Neoplasms | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Whole-Body Irradiation | Major topic |
| Acute Disease | |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Child, Preschool | |
| Female | |
| Histocompatibility | |
| Humans | |
| Infant | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Risk Factors | |
| Siblings | |
| Survival Rate | |
| Tissue Donors | |
| Transplantation Conditioning | |
| Transplantation, Homologous | |
| Unrelated Donors | |
| Young Adult |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5U01HL069294 | NHLBI NIH HHS | United States | U01HL069294 | PubMed and NIH | NIH RePORTER |
| U24 CA076518 | NCI NIH HHS | United States | U24CA076518 | PubMed and NIH | NIH RePORTER |
| U24-CA76518 | NCI NIH HHS | United States | U24CA076518 | PubMed and NIH | NIH RePORTER |
| U01 HL069294 | NHLBI NIH HHS | United States | U01HL069294 | PubMed and NIH | NIH RePORTER |
| P01 CA047741 | NCI NIH HHS | United States | P01CA047741 | PubMed and NIH | NIH RePORTER |
| HHSH234200637015C | PHS HHS | United States | PubMed | PubMed |
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT05350163 | T-cell Receptor α/β Depleted Donor Lymphocyte Infusion | Background | ClinicalTrials.gov | |
| NCT06840756 | Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes | Background | ClinicalTrials.gov | |
| NCT07576699 | CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD) | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 22223818 | The Serenity Prayer for acute GVHD. | https://conductscience.org/library/papers/22223818 |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19714314 | Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells. | Mol Cells | 2009 | https://conductscience.org/library/papers/19714314 | PubMed |
| 2 | 7670393 | Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. | Bone Marrow Transplant | 1995 | https://conductscience.org/library/papers/7670393 | PubMed |
| 3 | 10204198 | Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. | Stat Med | 1999 | https://conductscience.org/library/papers/10204198 | PubMed |
| 4 | 17025025 | Acute graft-versus-host disease. The incidence and risk factors. | Ann Transplant | 2006 | https://conductscience.org/library/papers/17025025 | PubMed |
| 5 | 9217189 | IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. | Br J Haematol | 1997 | https://conductscience.org/library/papers/9217189 | PubMed |
| 6 | 17348080 | Analyzing survival curves at a fixed point in time. | Stat Med | 2007 | https://conductscience.org/library/papers/17348080 | PubMed |
| 7 | 14993883 | Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. | Biol Blood Marrow Transplant | 2004 | https://conductscience.org/library/papers/14993883 | PubMed |
| 8 | 16946302 | Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. | Blood | 2006 | https://conductscience.org/library/papers/16946302 | PubMed |
| 9 | 3288872 | Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation. | N Engl J Med | 1988 | https://conductscience.org/library/papers/3288872 | PubMed |
| 10 | 15113759 | Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. | Blood | 2004 | https://conductscience.org/library/papers/15113759 | PubMed |
| 11 | 6337323 | Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6337323 | PubMed |
| 12 | 12203168 | Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors. | Clin Infect Dis | 2002 | https://conductscience.org/library/papers/12203168 | PubMed |
| 13 | 12663454 | Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. | Blood | 2003 | https://conductscience.org/library/papers/12663454 | PubMed |
| 14 | 2249952 | Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. | Hum Immunol | 1990 | https://conductscience.org/library/papers/2249952 | PubMed |
| 15 | 19203728 | Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. | Biol Blood Marrow Transplant | 2009 | https://conductscience.org/library/papers/19203728 | PubMed |
| 16 | 16210336 | Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. | Blood | 2006 | https://conductscience.org/library/papers/16210336 | PubMed |
| 17 | 2164434 | Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group. | Bone Marrow Transplant | 1990 | https://conductscience.org/library/papers/2164434 | PubMed |
| 18 | 9894716 | A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. | Bone Marrow Transplant | 1998 | https://conductscience.org/library/papers/9894716 | PubMed |
| 19 | 10197799 | Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation. | Bone Marrow Transplant | 1999 | https://conductscience.org/library/papers/10197799 | PubMed |
| 20 | 19224849 | HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19224849 | PubMed |
Cited by368
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 573 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42851397 | Time-adjusted direct medical costs of moderate-to-severe chronic graft-versus-host disease: a retrospective two-center cost analysis in Türkiye. | Front Public Health | 2026 | https://conductscience.org/library/papers/42851397 | PubMed |
| 42844290 | Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42844290 | PubMed |
| 42782891 | Idiopathic Pneumonia Syndrome and Pulmonary Toxicity After Total Body Irradiation for Bone Marrow Transplantation in the Modern Transplant Era. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42782891 | PubMed |
| 42754641 | GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42754641 | PubMed |
| 42734876 | Biologic Therapies for Alleviating Neurodegeneration in Lysosomal Storage Diseases. | BioDrugs | 2026 | https://conductscience.org/library/papers/42734876 | PubMed |
| 42676515 | Early and sex-specific dynamic changes of the modified Glasgow Prognostic Score correlate with survival and immunotoxicities in patients undergoing allogeneic hematopoietic stem cell transplantation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42676515 | PubMed |
| 42671266 | HLA-A ∗01:01 Allele Is Associated With Increased Risk of Transplant-Related Mortality After MHC Matched Unmodified Allogeneic Hematopoietic Stem Cell Transplantation. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42671266 | PubMed |
| 42612728 | Outcomes After Matched Sibling Donor Versus Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis. | Transplant Cell Ther | 2026 | https://conductscience.org/library/papers/42612728 | PubMed |
| 42533070 | The real-world safety of ruxolitinib in graft-versus-host disease treatment: a pharmacovigilance study based on the FDA adverse event reporting system. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42533070 | PubMed |
| 42367753 | Advances in graft-versus-host disease: emerging therapeutic strategies, biomarker discoveries, and innovative treatment approaches. | Front Immunol | 2026 | https://conductscience.org/library/papers/42367753 | PubMed |
| 42215807 | Cyclosporine in hematological disorders: mechanisms, clinical practice and emerging advances. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42215807 | PubMed |
| 41986581 | Impact of lymphocyte p-glycoprotein activity on development of graft-versus-host disease after stem cell transplantation. | Int J Hematol | 2026 | https://conductscience.org/library/papers/41986581 | PubMed |
| 41904242 | Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/41904242 | PubMed |
| 41787572 | The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/41787572 | PubMed |
| 41686349 | Recent advances in the pathophysiology of acute and chronic graft-versus-host disease. | Int J Hematol | 2026 | https://conductscience.org/library/papers/41686349 | PubMed |
| 41681858 | The Effect of Post-Transplant Cyclophosphamide Administration on Graft-Versus-Host Disease in Allogeneic Bone Marrow Transplantation. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681858 | PubMed |
| 41643175 | Differential effects of GVHD therapies on intestinal epithelium. | Blood Adv | 2026 | https://conductscience.org/library/papers/41643175 | PubMed |
| 41611709 | Circadian fluctuation of soluble CD26 dictates the impact of the timing of cord blood transplantation on acute graft-versus-host disease. | Nat Commun | 2026 | https://conductscience.org/library/papers/41611709 | PubMed |
| 41498421 | Validated clinical risk score for acute graft-versus-host disease in adult allogeneic hematopoietic cell transplantation. | Blood Adv | 2026 | https://conductscience.org/library/papers/41498421 | PubMed |
| 41413745 | Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation. | Eur J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/41413745 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22010102
GET https://conductscience.org/api/papers/v1/22010102/authors?page=2